This is a table of type unigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
unigram | frequency |
---|---|
patients | 6631 |
covid | 1613 |
patient | 1326 |
study | 1319 |
vte | 1301 |
risk | 1263 |
treatment | 1205 |
clinical | 1005 |
disease | 964 |
associated | 910 |
therapy | 899 |
care | 898 |
data | 896 |
may | 875 |
hospital | 792 |
acute | 785 |
high | 705 |
years | 690 |
time | 685 |
days | 647 |
results | 636 |
cell | 630 |
medical | 614 |
age | 611 |
severe | 601 |
vs | 595 |
using | 594 |
use | 586 |
diagnosis | 579 |
analysis | 572 |
one | 569 |
pediatric | 567 |
venous | 553 |
studies | 524 |
case | 523 |
significant | 522 |
blood | 510 |
icu | 507 |
reported | 506 |
will | 500 |
used | 497 |
mortality | 493 |
higher | 493 |
management | 488 |
based | 479 |
received | 479 |
background | 478 |
increased | 474 |
compared | 472 |
due | 471 |
outcomes | 470 |
mean | 468 |
post | 462 |
including | 459 |
also | 457 |
two | 450 |
levels | 441 |
cases | 441 |
bleeding | 440 |
however | 437 |
group | 433 |
without | 432 |
children | 431 |
non | 430 |
months | 430 |
prophylaxis | 424 |
cells | 419 |
year | 418 |
well | 417 |
thrombosis | 416 |
mg | 412 |
brain | 409 |
included | 409 |
median | 407 |
outcome | 406 |
method | 402 |
dose | 401 |
performed | 400 |
low | 393 |
stroke | 391 |
day | 382 |
pulmonary | 378 |
showed | 378 |
within | 376 |
hospitalized | 374 |
identified | 374 |
design | 373 |
cancer | 371 |
infection | 370 |
anticoagulation | 365 |
incidence | 364 |
thromboembolism | 364 |
first | 362 |
significantly | 362 |
following | 358 |
factors | 354 |
complications | 351 |
ill | 350 |
developed | 348 |
rate | 348 |
hours | 347 |
primary | 335 |
treated | 334 |
review | 329 |
injury | 327 |
among | 320 |
syndrome | 318 |
population | 317 |
score | 314 |
objectives | 313 |
early | 312 |
total | 312 |
respiratory | 311 |
admission | 310 |
dimer | 309 |
rates | 306 |
positive | 304 |
pe | 303 |
retrospective | 302 |
thromboprophylaxis | 301 |
chemotherapy | 300 |
related | 300 |
prior | 293 |
hemorrhage | 290 |
evidence | 289 |
found | 287 |
report | 286 |
scd | 284 |
anti | 283 |
events | 283 |
lower | 282 |
cohort | 282 |
old | 280 |
coronavirus | 277 |
admitted | 276 |
center | 276 |
three | 276 |
health | 275 |
cd | 274 |
common | 272 |
platelet | 271 |
tumor | 269 |
range | 268 |
standard | 267 |
status | 266 |
findings | 262 |
guidelines | 262 |
level | 261 |
cerebral | 259 |
potential | 257 |
ci | 255 |
initial | 252 |
failure | 252 |
heparin | 251 |
present | 251 |
pain | 251 |
ct | 250 |
response | 250 |
symptoms | 247 |
elevated | 247 |
increase | 246 |
number | 238 |
despite | 236 |
discharge | 236 |
new | 235 |
ml | 235 |
presented | 234 |
respectively | 233 |
dvt | 232 |
death | 231 |
poor | 231 |
critically | 231 |
test | 230 |
baseline | 230 |
diagnosed | 229 |
follow | 229 |
pneumonia | 228 |
pre | 228 |
sars | 225 |
imaging | 225 |
considered | 225 |
normal | 224 |
coagulation | 223 |
lmwh | 222 |
coagulopathy | 221 |
trial | 221 |
specific | 220 |
kg | 220 |
ich | 220 |
system | 220 |
given | 220 |
improve | 219 |
therapeutic | 217 |
history | 217 |
novel | 217 |
survival | 216 |
cov | 215 |
factor | 214 |
demonstrated | 214 |
anticoagulant | 210 |
states | 208 |
decreased | 207 |
testing | 206 |
administration | 205 |
function | 205 |
underwent | 205 |
effects | 204 |
need | 204 |
control | 202 |
per | 202 |
multiple | 201 |
screening | 201 |
united | 201 |
determine | 200 |
role | 199 |
intervention | 199 |
assessment | 199 |
negative | 198 |
overall | 198 |
groups | 197 |
prevention | 197 |
known | 197 |
revealed | 194 |
duration | 192 |
enoxaparin | 192 |
leukemia | 192 |
likely | 192 |
receiving | 191 |
prevalence | 190 |
improvement | 190 |
unit | 189 |
although | 189 |
embolism | 189 |
monitoring | 188 |
effect | 187 |
required | 187 |
model | 186 |
count | 185 |
course | 184 |
period | 183 |
additional | 181 |
information | 181 |
support | 181 |
observed | 180 |
thrombotic | 179 |
male | 179 |
daily | 179 |
identify | 178 |
tumors | 178 |
development | 178 |
bone | 178 |
efficacy | 177 |
cardiac | 177 |
activity | 177 |
marrow | 176 |
life | 175 |
criteria | 175 |
available | 173 |
safety | 173 |
drug | 173 |
single | 173 |
secondary | 173 |
conducted | 172 |
major | 172 |
mri | 172 |
intensive | 172 |
trials | 172 |
less | 171 |
collected | 171 |
conclusion | 171 |
versus | 170 |
hsct | 170 |
research | 169 |
confirmed | 169 |
weeks | 168 |
presence | 168 |
different | 168 |
improved | 167 |
suggest | 167 |
evaluate | 167 |
defined | 166 |
oral | 166 |
evaluated | 165 |
protocol | 165 |
literature | 165 |
recommended | 164 |
left | 164 |
intracranial | 164 |
recent | 164 |
randomized | 163 |
expression | 163 |
subjects | 163 |
characteristics | 163 |
rare | 163 |
female | 161 |
average | 161 |
setting | 161 |
parameters | 161 |
laboratory | 161 |
cause | 160 |
many | 160 |
gene | 160 |
limited | 160 |
hospitalization | 159 |
ischemic | 159 |
transfusion | 159 |
induced | 159 |
oncology | 158 |
i | 158 |
impact | 158 |
infections | 157 |
weight | 157 |
scores | 157 |
presentation | 156 |
quality | 156 |
prospective | 156 |
critical | 156 |
important | 155 |
four | 155 |
neurological | 155 |
needed | 155 |
similar | 154 |
reduced | 153 |
analyzed | 152 |
approach | 152 |
evaluation | 152 |
right | 151 |
doses | 151 |
anemia | 151 |
chronic | 151 |
sah | 150 |
addition | 150 |
renal | 150 |
several | 150 |
iv | 150 |
pressure | 150 |
association | 149 |
stay | 148 |
difference | 148 |
describe | 147 |
aml | 147 |
changes | 146 |
thrombocytopenia | 146 |
practice | 146 |
inflammatory | 146 |
benefit | 146 |
current | 146 |
severity | 145 |
tbi | 145 |
assess | 144 |
described | 144 |
immune | 144 |
family | 143 |
reviewed | 143 |
large | 143 |
vascular | 143 |
include | 143 |
assessed | 142 |
state | 141 |
least | 140 |
transplant | 140 |
differences | 140 |
provide | 140 |
type | 139 |
decrease | 139 |
completed | 139 |
previously | 138 |
surgical | 138 |
surgery | 138 |
mechanical | 138 |
prophylactic | 137 |
receive | 137 |
refractory | 136 |
followed | 136 |
thromboembolic | 135 |
decision | 135 |
adult | 135 |
icp | 135 |
dysfunction | 135 |
often | 134 |
fever | 134 |
values | 133 |
reports | 133 |
tissue | 133 |
eeg | 131 |
especially | 131 |
possible | 131 |
consistent | 131 |
seen | 131 |
infusion | 130 |
grade | 130 |
appropriate | 128 |
flow | 128 |
requiring | 128 |
size | 128 |
regarding | 127 |
induction | 127 |
home | 127 |
whether | 126 |
chest | 126 |
small | 125 |
sickle | 125 |
hemoglobin | 125 |
line | 125 |
guidance | 124 |
end | 124 |
edema | 124 |
emergency | 123 |
seizures | 123 |
scale | 123 |
month | 122 |
dl | 122 |
five | 122 |
loss | 121 |
china | 119 |
process | 119 |
neurocritical | 119 |
shown | 119 |
team | 119 |
even | 119 |
survivors | 118 |
via | 118 |
diagnostic | 118 |
previous | 118 |
ultrasound | 118 |
staff | 117 |
died | 117 |
systemic | 117 |
series | 117 |
initiation | 117 |
obtained | 117 |
centers | 116 |
reduce | 116 |
chart | 116 |
remains | 116 |
arterial | 116 |
index | 116 |
effective | 116 |
change | 115 |
ufh | 115 |
survey | 115 |
genes | 115 |
according | 115 |
value | 115 |
central | 114 |
inflammation | 114 |
prognosis | 114 |
deep | 114 |
greater | 113 |
heart | 113 |
sample | 113 |
key | 113 |
institution | 112 |
inpatient | 112 |
ratio | 112 |
liver | 112 |
started | 111 |
stem | 111 |
providers | 111 |
cord | 111 |
second | 111 |
currently | 111 |
mutation | 110 |
long | 110 |
adverse | 110 |
measured | 109 |
experience | 109 |
occurred | 109 |
vein | 109 |
participants | 109 |
develop | 108 |
communication | 108 |
mutations | 108 |
continuous | 107 |
young | 107 |
university | 107 |
term | 107 |
abnormal | 107 |
symptomatic | 107 |
lesions | 107 |
event | 107 |
therapies | 106 |
complication | 106 |
onset | 106 |
activation | 106 |
regression | 105 |
interventions | 105 |
placement | 105 |
enrolled | 105 |
minutes | 105 |
lack | 105 |
volume | 104 |
continued | 104 |
hospitals | 104 |
stage | 104 |
serum | 104 |
phase | 104 |
molecular | 104 |
either | 103 |
functional | 103 |
frequency | 103 |
direct | 102 |
transfusions | 101 |
protocols | 101 |
since | 101 |
prolonged | 101 |
noted | 101 |
program | 101 |
diffuse | 100 |
measures | 100 |
recommend | 100 |
lead | 100 |
agents | 100 |
dosing | 100 |
head | 99 |
therefore | 99 |
initiated | 99 |
commonly | 99 |
knowledge | 99 |
society | 99 |
gcs | 99 |
genetic | 99 |
fibrinogen | 99 |
length | 99 |
sepsis | 98 |
viral | 98 |
bilateral | 98 |
published | 98 |
procedures | 97 |
good | 97 |
authors | 96 |
suggests | 96 |
week | 96 |
episodes | 96 |
mild | 96 |
traumatic | 96 |
biopsy | 96 |
times | 96 |
like | 96 |
date | 96 |
neutrophil | 96 |
complete | 96 |
cost | 95 |
american | 95 |
morbidity | 95 |
mass | 95 |
organ | 95 |
education | 95 |
metastatic | 95 |
implementation | 95 |
variables | 95 |
result | 94 |
suspected | 94 |
leading | 94 |
approximately | 94 |
tests | 94 |
parents | 94 |
majority | 93 |
international | 93 |
hydroxyurea | 93 |
reduction | 92 |
clinically | 92 |
abnormalities | 92 |
subarachnoid | 92 |
extended | 92 |
mm | 92 |
features | 92 |
better | 92 |
sirolimus | 92 |
order | 91 |
excluded | 91 |
absence | 91 |
tool | 91 |
various | 91 |
ventilation | 91 |
administered | 91 |
medication | 91 |
illness | 91 |
relapse | 91 |
prevent | 90 |
families | 90 |
physical | 90 |
intravenous | 90 |
adults | 90 |
six | 90 |
later | 90 |
hematology | 89 |
making | 89 |
los | 89 |
hypertension | 89 |
consent | 89 |
provided | 89 |
general | 89 |
recurrent | 89 |
epilepticus | 88 |
controlled | 88 |
training | 88 |
ii | 88 |
medications | 88 |
objective | 88 |
table | 88 |
potentially | 88 |
future | 87 |
characterized | 87 |
mmhg | 87 |
co | 87 |
optimal | 87 |
lymphoma | 86 |
pathway | 86 |
arrest | 86 |
recommendations | 86 |
access | 86 |
seizure | 86 |
distress | 85 |
ongoing | 85 |
protein | 85 |
hb | 85 |
models | 85 |
national | 85 |
agent | 85 |
studied | 85 |
every | 85 |
antithrombotic | 85 |
csf | 85 |
made | 85 |
point | 85 |
exposure | 85 |
childhood | 84 |
records | 84 |
min | 84 |
neurologic | 84 |
strategies | 84 |
adherence | 84 |
lung | 83 |
across | 83 |
older | 83 |
analyses | 83 |
cardiovascular | 83 |
temperature | 82 |
rivaroxaban | 82 |
peripheral | 82 |
thalassemia | 82 |
full | 82 |
documented | 82 |
successful | 81 |
must | 81 |
lines | 80 |
patterns | 80 |
frequent | 80 |
cns | 80 |
strategy | 80 |
combination | 80 |
trauma | 80 |
regimen | 80 |
another | 80 |
article | 80 |
pandemic | 79 |
inhibitors | 79 |
neutropenia | 79 |
cultures | 79 |
database | 79 |
inhibitor | 79 |
diseases | 79 |
placebo | 79 |
recovery | 79 |
presenting | 79 |
january | 78 |
free | 78 |
controls | 78 |
help | 78 |
evd | 78 |
frequently | 78 |
done | 78 |
medicine | 78 |
electronic | 78 |
experienced | 78 |
hematoma | 78 |
still | 78 |
rapid | 78 |
recorded | 78 |
acutely | 78 |
target | 78 |
clinic | 78 |
require | 77 |
resolution | 77 |
plasma | 77 |
complicated | 77 |
undergoing | 77 |
local | 77 |
signs | 77 |
panel | 77 |
burden | 77 |
iu | 76 |
determined | 76 |
disorder | 76 |
longer | 76 |
routine | 76 |
multi | 76 |
condition | 76 |
guideline | 76 |
virus | 76 |
methods | 76 |
il | 76 |
calculated | 76 |
work | 76 |
st | 76 |
spontaneous | 75 |
relevant | 75 |
correlated | 75 |
standardized | 75 |
healthy | 75 |
iron | 75 |
complex | 75 |
relationship | 75 |
infectious | 75 |
estimated | 74 |
neuroblastoma | 74 |
units | 74 |
discharged | 74 |
statistical | 74 |
healthcare | 74 |
iqr | 74 |
deficiency | 74 |
samples | 74 |
consensus | 74 |
intracerebral | 73 |
subsequent | 73 |
antibodies | 73 |
counts | 73 |
underlying | 73 |
wuhan | 73 |
conditions | 73 |
aged | 73 |
receptor | 72 |
scan | 72 |
clearance | 72 |
questions | 72 |
active | 72 |
involvement | 72 |
might | 72 |
occur | 72 |
correlation | 72 |
developing | 71 |
cycles | 71 |
eligible | 71 |
toxicity | 71 |
disorders | 71 |
physicians | 71 |
causes | 71 |
department | 70 |
increasing | 70 |
statistically | 70 |
guide | 70 |
inclusion | 70 |
dic | 70 |
se | 69 |
subsequently | 69 |
part | 69 |
admissions | 69 |
inhibition | 69 |
outpatient | 69 |
self | 69 |
transplantation | 69 |
hct | 69 |
us | 69 |
detected | 69 |
oxygen | 69 |
achieved | 69 |
body | 69 |
established | 69 |
particularly | 68 |
site | 68 |
endothelial | 68 |
white | 68 |
females | 68 |
independent | 68 |
remained | 68 |
vitamin | 68 |
hu | 68 |
ards | 68 |
radiation | 68 |
seven | 67 |
informed | 67 |
involved | 67 |
meta | 67 |
human | 67 |
asah | 67 |
growth | 67 |
targeted | 67 |
malignancy | 67 |
delayed | 67 |
invasive | 67 |
needs | 67 |
examination | 67 |
half | 67 |
iii | 67 |
systematic | 66 |
infarction | 66 |
pt | 66 |
unique | 66 |
red | 66 |
srse | 66 |
utilization | 66 |
alone | 66 |
products | 66 |
proportion | 66 |
moderate | 66 |
markers | 65 |
drugs | 65 |
goal | 65 |
ds | 65 |
aim | 65 |
nurses | 65 |
approved | 65 |
platelets | 65 |
artery | 65 |
institutional | 65 |
myocardial | 65 |
predict | 65 |
algorithm | 65 |
perfusion | 65 |
observational | 65 |
myeloid | 64 |
initially | 64 |
placed | 64 |
exam | 64 |
sodium | 64 |
successfully | 64 |
hr | 64 |
sequencing | 64 |
modified | 64 |
os | 63 |
progressive | 63 |
qi | 63 |
osteosarcoma | 63 |
indicated | 63 |
yet | 63 |
points | 63 |
intensity | 63 |
ed | 63 |
nine | 63 |
side | 63 |
understanding | 63 |
identification | 63 |
completion | 63 |
gvhd | 62 |
remission | 62 |
treat | 62 |
treatments | 62 |
fluid | 62 |
ability | 62 |
location | 62 |
suggesting | 62 |
relapsed | 62 |
safe | 62 |
anticoagulants | 62 |
asymptomatic | 61 |
demographics | 61 |
lymphoblastic | 61 |
physician | 61 |
contrast | 61 |
selected | 61 |
predictors | 61 |
best | 61 |
benefits | 61 |
antibiotics | 61 |
stable | 61 |
malignancies | 60 |
worsening | 60 |
last | 60 |
xa | 60 |
demonstrate | 60 |
creatinine | 60 |
cm | 60 |
expansion | 60 |
mechanisms | 60 |
academic | 60 |
ecmo | 60 |
sex | 60 |
existing | 59 |
resulting | 59 |
delay | 59 |
global | 59 |
intravascular | 59 |
reporting | 59 |
males | 59 |
members | 59 |
retrospectively | 59 |
compare | 59 |
larger | 59 |
past | 59 |
sarcoma | 58 |
tested | 58 |
useful | 58 |
solid | 58 |
form | 58 |
pet | 58 |
symptom | 58 |
extensive | 58 |
december | 58 |
individuals | 58 |
catheter | 58 |
antibody | 57 |
procedure | 57 |
tcd | 57 |
necessary | 57 |
show | 57 |
bacteremia | 57 |
adjusted | 57 |
highest | 57 |
enrollment | 57 |
antiplatelet | 57 |
involving | 57 |
derived | 57 |
resulted | 57 |
logistic | 57 |
unknown | 56 |
difficult | 56 |
isolated | 56 |
practices | 56 |
none | 56 |
late | 56 |
culture | 56 |
car | 56 |
suspicion | 56 |
cytokine | 56 |
start | 56 |
randomization | 56 |
assessments | 56 |
additionally | 56 |
steroids | 56 |
predictive | 56 |
neuro | 56 |
eight | 56 |
sd | 56 |
detection | 56 |
voc | 56 |
responses | 56 |
measurement | 55 |
along | 55 |
aggressive | 55 |
expert | 55 |
absolute | 55 |
utilized | 55 |
bmi | 55 |
area | 55 |
met | 55 |
clinicians | 55 |
dci | 55 |
project | 55 |
implemented | 55 |
warfarin | 55 |
journal | 55 |
typically | 55 |
classified | 55 |
scans | 55 |
mrs | 55 |
partial | 54 |
significance | 54 |
importance | 54 |
intra | 54 |
hematopoietic | 54 |
ambulatory | 54 |
gender | 54 |
sensitivity | 54 |
infected | 54 |
vasospasm | 54 |
remain | 54 |
vwf | 54 |
etiology | 54 |
progression | 54 |
ischemia | 53 |
child | 53 |
measure | 53 |
validated | 53 |
understand | 53 |
participation | 53 |
upper | 53 |
unclear | 53 |
able | 53 |
aki | 53 |
social | 53 |
donor | 53 |
twenty | 53 |
map | 53 |
prognostic | 52 |
comparison | 52 |
world | 52 |
rituximab | 52 |
sought | 52 |
populations | 52 |
challenging | 52 |
deaths | 52 |
fellows | 52 |
spinal | 52 |
coma | 52 |
maintenance | 52 |
mediated | 52 |
caused | 52 |
prediction | 52 |
interim | 52 |
malignant | 52 |
ages | 51 |
pathogenesis | 51 |
hemophilia | 51 |
maximum | 51 |
final | 51 |
doacs | 51 |
coronary | 51 |
tpa | 51 |
fusion | 51 |
school | 51 |
ng | 51 |
consider | 51 |
transfer | 51 |
twice | 51 |
interest | 51 |
resources | 51 |
indication | 51 |
favorable | 51 |
profile | 51 |
pharmacologic | 51 |
atypical | 51 |
investigation | 51 |
recurrence | 51 |
nursing | 51 |
college | 50 |
th | 50 |
recently | 50 |
specificity | 50 |
aneurysm | 50 |
indications | 50 |
finding | 50 |
cardiology | 50 |
risks | 50 |
hemorrhagic | 50 |
intermediate | 50 |
relative | 50 |
selection | 50 |
affected | 50 |
persistent | 50 |
delirium | 50 |
comprehensive | 50 |
marker | 50 |
deterioration | 50 |
lymphocyte | 50 |
countries | 50 |
proliferation | 50 |
transition | 50 |
furthermore | 49 |
little | 49 |
fibrin | 49 |
kidney | 49 |
medically | 49 |
pattern | 49 |
fibrinolysis | 49 |
june | 49 |
pts | 49 |
advanced | 49 |
committee | 49 |
record | 49 |
hepatic | 49 |
infusions | 49 |
interactions | 49 |
ventricular | 49 |
tracheostomy | 49 |
effectiveness | 49 |
hypothesized | 49 |
endovascular | 48 |
mechanism | 48 |
institutions | 48 |
next | 48 |
now | 48 |
nk | 48 |
braf | 48 |
tolerated | 48 |
demographic | 48 |
aptt | 48 |
resection | 48 |
hl | 48 |
main | 48 |
infants | 48 |
expected | 48 |
fatal | 48 |
examined | 48 |
plan | 48 |
whole | 48 |
performance | 48 |
aimed | 48 |
regimens | 48 |
repeat | 48 |
occurrence | 48 |
hour | 48 |
third | 48 |
appears | 47 |
expressed | 47 |
occurs | 47 |
costs | 47 |
hlh | 47 |
acs | 47 |
beta | 47 |
workup | 47 |
padua | 47 |
whereas | 47 |
suggested | 47 |
aspirin | 47 |
minimal | 47 |
tertiary | 47 |
concentration | 47 |
diagnoses | 47 |
extremity | 47 |
stress | 47 |
led | 47 |
disseminated | 47 |
aneurysmal | 47 |
short | 47 |
provides | 47 |
damage | 46 |
consecutive | 46 |
diabetes | 46 |
cycle | 46 |
march | 46 |
individual | 46 |
matched | 46 |
angiography | 46 |
managed | 46 |
adequate | 46 |
remaining | 46 |
hemolysis | 46 |
autoimmune | 46 |
mcg | 46 |
requires | 46 |
lesion | 46 |
external | 46 |
cumulative | 46 |
bedside | 46 |
finally | 46 |
reducing | 46 |
adolescents | 46 |
sites | 46 |
registry | 46 |
posterior | 45 |
region | 45 |
rapidly | 45 |
reserved | 45 |
satisfaction | 45 |
mrd | 45 |
pcr | 45 |
shift | 45 |
hypotension | 45 |
reversal | 45 |
throughout | 45 |
dependent | 45 |
affect | 45 |
alpha | 45 |
percentage | 45 |
atrial | 45 |
real | 45 |
metabolic | 45 |
compression | 45 |
settings | 45 |
pathology | 45 |
moreover | 45 |
visit | 45 |
newly | 45 |
independently | 44 |
metastasis | 44 |
hemodynamic | 44 |
copyright | 44 |
investigator | 44 |
mice | 44 |
acquired | 44 |
scientific | 44 |
percent | 44 |
particular | 44 |
antibiotic | 44 |
acid | 44 |
preliminary | 44 |
code | 44 |
fondaparinux | 44 |
middle | 44 |
delivery | 44 |
hypercoagulability | 44 |
detect | 44 |
race | 44 |
skin | 44 |
descriptive | 44 |
fold | 44 |
purpose | 44 |
barriers | 44 |
interval | 44 |
predicted | 44 |
apixaban | 44 |
pres | 43 |
obesity | 43 |
fibrillation | 43 |
monitored | 43 |
cincinnati | 43 |
threatening | 43 |
includes | 43 |
strongly | 43 |
occurring | 43 |
documentation | 43 |
highly | 43 |
timing | 43 |
immunity | 43 |
doc | 43 |
thrombolysis | 43 |
rna | 43 |
collection | 43 |
provider | 43 |
worse | 43 |
congenital | 43 |
multicenter | 43 |
haemostasis | 43 |
challenges | 43 |
viii | 43 |
search | 43 |
rights | 43 |
starting | 43 |
vessel | 43 |
component | 43 |
wide | 42 |
ph | 42 |
ebv | 42 |
degree | 42 |
differential | 42 |
cytokines | 42 |
conventional | 42 |
treating | 42 |
shock | 42 |
questionnaire | 42 |
nccu | 42 |
hypothesis | 42 |
warranted | 42 |
directly | 42 |
trend | 42 |
focal | 42 |
limit | 42 |
causing | 42 |
concern | 42 |
measurements | 42 |
implications | 42 |
pbto | 42 |
represents | 42 |
comfort | 42 |
contact | 42 |
mp | 42 |
cognitive | 42 |
crisis | 42 |
encephalopathy | 42 |
lab | 41 |
clot | 41 |
visits | 41 |
educational | 41 |
identifying | 41 |
usually | 41 |
feasible | 41 |
planned | 41 |
investigate | 41 |
stratification | 41 |
cross | 41 |
quantitative | 41 |
lch | 41 |
abdominal | 41 |
dna | 41 |
internal | 41 |
doi | 41 |
younger | 41 |
validation | 41 |
concentrations | 41 |
crs | 41 |
examine | 41 |
cr | 41 |
comorbidities | 41 |
systems | 41 |
sdh | 41 |
predictor | 41 |
designed | 41 |
april | 41 |
caregivers | 41 |
clear | 41 |
isth | 41 |
highlights | 41 |
instability | 41 |
phenotype | 41 |
focus | 40 |
serious | 40 |
suppression | 40 |
sc | 40 |
referral | 40 |
immediate | 40 |
choice | 40 |
indicate | 40 |
activated | 40 |
generation | 40 |
network | 40 |
around | 40 |
cellular | 40 |
reactivity | 40 |
glasgow | 40 |
exact | 40 |
variable | 40 |
plasminogen | 40 |
phone | 40 |
assay | 40 |
mds | 40 |
product | 40 |
nct | 39 |
alterations | 39 |
appear | 39 |
limitations | 39 |
combined | 39 |
nausea | 39 |
hypoxia | 39 |
estimate | 39 |
accepted | 39 |
assessing | 39 |
title | 39 |
immediately | 39 |
temporal | 39 |
inpatients | 39 |
compliance | 39 |
injection | 39 |
formation | 39 |
rather | 39 |
aed | 39 |
glucose | 39 |
mobility | 39 |
concerns | 39 |
residents | 39 |
itp | 39 |
graft | 39 |
multidisciplinary | 39 |
approval | 39 |
continue | 38 |
recognition | 38 |
agvhd | 38 |
resolved | 38 |
hemolytic | 38 |
created | 38 |
play | 38 |
context | 38 |
ten | 38 |
pathways | 38 |
elevation | 38 |
multivariable | 38 |
metastases | 38 |
confidence | 38 |
investigated | 38 |
variant | 38 |
surface | 38 |
headache | 38 |
cohorts | 38 |
pca | 38 |
replacement | 38 |
options | 37 |
though | 37 |
applied | 37 |
arrival | 37 |
issues | 37 |
place | 37 |
become | 37 |
nature | 37 |
hypercoagulable | 37 |
donors | 37 |
tomography | 37 |
valve | 37 |
pa | 37 |
pilot | 37 |
id | 37 |
tract | 37 |
aneurysms | 37 |
subgroup | 37 |
aya | 37 |
application | 37 |
ivig | 37 |
substantial | 37 |
febrile | 37 |
protected | 37 |
towards | 37 |
steroid | 37 |
concurrent | 37 |
empiric | 37 |
thirty | 37 |
feasibility | 37 |
doac | 37 |
impairment | 37 |
influenza | 37 |
attention | 37 |
proximal | 37 |
source | 37 |
parenteral | 37 |
version | 37 |
midline | 37 |
obese | 37 |
hydrocephalus | 36 |
regulated | 36 |
deficits | 36 |
circulation | 36 |
discussion | 36 |
requirements | 36 |
reasons | 36 |
wt | 36 |
responsible | 36 |
bias | 36 |
variability | 36 |
chromosome | 36 |
linear | 36 |
concomitant | 36 |
overload | 36 |
sha | 36 |
consciousness | 36 |
preferred | 36 |
exists | 36 |
exclusion | 36 |
hemostasis | 36 |
pharmacological | 36 |
multivariate | 36 |
areas | 36 |
sessions | 36 |
uid | 36 |
institute | 36 |
specifically | 36 |
open | 36 |
malformations | 36 |
light | 36 |
strong | 36 |
host | 36 |
unfractionated | 36 |
focused | 36 |
prothrombotic | 35 |
toxicities | 35 |
mainly | 35 |
basis | 35 |
types | 35 |
screened | 35 |
parental | 35 |
brainstem | 35 |
vitro | 35 |
univariate | 35 |
devices | 35 |
alternative | 35 |
targeting | 35 |
sds | 35 |
curriculum | 35 |
undergo | 35 |
urine | 35 |
bp | 35 |
threshold | 35 |
occlusion | 35 |
mental | 35 |
nurse | 35 |
consideration | 35 |
public | 35 |
radiographic | 35 |
adjusting | 35 |
weekly | 35 |
failed | 35 |
utilizing | 35 |
address | 35 |
operative | 35 |
associations | 34 |
interviews | 34 |
depression | 34 |
experts | 34 |
spine | 34 |
vivo | 34 |
trends | 34 |
ikaros | 34 |
subject | 34 |
endpoint | 34 |
beneficial | 34 |
rarely | 34 |
demonstrates | 34 |
ceeg | 34 |
ferritin | 34 |
pdsa | 34 |
approaches | 34 |
binding | 34 |
option | 34 |
represent | 34 |
peak | 34 |
weaning | 34 |
unless | 34 |
sided | 34 |
allow | 34 |
increases | 34 |
hypertonic | 34 |
note | 34 |
shows | 34 |
nihss | 34 |
cortical | 34 |
hispanic | 34 |
cervical | 34 |
markedly | 34 |
fibrinolytic | 34 |
categories | 33 |
showing | 33 |
teg | 33 |
tube | 33 |
correlate | 33 |
prothrombin | 33 |
herniation | 33 |
clopidogrel | 33 |
alveolar | 33 |
intubation | 33 |
outside | 33 |
fxa | 33 |
bacterial | 33 |
bolus | 33 |
pupil | 33 |
observation | 33 |
anc | 33 |
proteins | 33 |
antiphospholipid | 33 |
presents | 33 |
organization | 33 |
biomarkers | 33 |
auc | 33 |
hematologic | 33 |
autopsy | 33 |
almost | 33 |
resistance | 33 |
splenectomy | 33 |
question | 33 |
plus | 33 |
urgent | 33 |
differ | 33 |
sedation | 33 |
cinv | 33 |
mixed | 33 |
monthly | 32 |
signaling | 32 |
pci | 32 |
departments | 32 |
subset | 32 |
expressions | 32 |
improving | 32 |
modalities | 32 |
inr | 32 |
lobe | 32 |
pooled | 32 |
widely | 32 |
spectrum | 32 |
annual | 32 |
limb | 32 |
close | 32 |
antihypertensive | 32 |
make | 32 |
localized | 32 |
palliative | 32 |
prospectively | 32 |
proven | 32 |
service | 32 |
generally | 32 |
probability | 32 |
texas | 32 |
hd | 32 |
ranged | 32 |
efs | 32 |
transferred | 32 |
awareness | 32 |
notable | 32 |
subcutaneous | 32 |
clotting | 32 |
enhanced | 32 |
person | 32 |
recognized | 32 |
contraindications | 32 |
taking | 32 |
resistant | 32 |
participant | 32 |
reason | 32 |
already | 32 |
subdural | 32 |
app | 32 |
withdrawal | 32 |
responded | 32 |
ldh | 32 |
emotional | 32 |
vaccine | 31 |
confirm | 31 |
statistics | 31 |
concerning | 31 |
organs | 31 |
july | 31 |
mtx | 31 |
primarily | 31 |
sent | 31 |
standardization | 31 |
supportive | 31 |
set | 31 |
septic | 31 |
personnel | 31 |
recombinant | 31 |
respondents | 31 |
ward | 31 |
extracellular | 31 |
avoid | 31 |
account | 31 |
practical | 31 |
alive | 31 |
cdc | 31 |
epilepsy | 31 |
monitor | 31 |
eligibility | 31 |
community | 31 |
decline | 31 |
cluster | 31 |
nf | 31 |
lymph | 31 |
ic | 31 |
rbc | 31 |
ultimately | 31 |
ketamine | 31 |
discussed | 31 |
technology | 31 |
production | 31 |
earlier | 31 |
encounters | 31 |
vwd | 31 |
programs | 31 |
systolic | 31 |
prescribed | 31 |
sufficient | 30 |
ck | 30 |
extremely | 30 |
lymphocytes | 30 |
computed | 30 |
sign | 30 |
survived | 30 |
categorized | 30 |
differentiation | 30 |
continues | 30 |
membrane | 30 |
relatively | 30 |
von | 30 |
mrna | 30 |
recipients | 30 |
similarly | 30 |
heterogeneity | 30 |
pd | 30 |
ivh | 30 |
back | 30 |
pk | 30 |
regions | 30 |
extubation | 30 |
kinase | 30 |
decisions | 30 |
oxygenation | 30 |
shorter | 30 |
andexanet | 30 |
collaboration | 30 |
york | 30 |
release | 30 |
much | 30 |
surveillance | 30 |
variation | 30 |
pao | 30 |
engraftment | 30 |
discontinued | 30 |
weighted | 30 |
document | 30 |
antigen | 30 |
felt | 30 |
hodgkin | 30 |
postoperative | 30 |
nicu | 30 |
episode | 30 |
targets | 30 |
discharges | 29 |
impaired | 29 |
evaluating | 29 |
manuscript | 29 |
likelihood | 29 |
onsd | 29 |
aggregation | 29 |
insurance | 29 |
explore | 29 |
npi | 29 |
processes | 29 |
learning | 29 |
essential | 29 |
sensitive | 29 |
sos | 29 |
absent | 29 |
surveys | 29 |
serial | 29 |
residual | 29 |
enhancement | 29 |
interaction | 29 |
sinus | 29 |
success | 29 |
generalized | 29 |
psychosocial | 29 |
cvc | 29 |
software | 29 |
codes | 29 |
emerging | 29 |
betrixaban | 29 |
antiviral | 29 |
neck | 29 |
medulloblastoma | 29 |
curve | 29 |
neurosurgical | 29 |
irb | 29 |
unrelated | 29 |
device | 28 |
hmb | 28 |
maintain | 28 |
random | 28 |
influence | 28 |
conditioning | 28 |
man | 28 |
blinded | 28 |
intermittent | 28 |
frontal | 28 |
estimates | 28 |
cytometry | 28 |
experimental | 28 |
encephalitis | 28 |
initiative | 28 |
fertility | 28 |
hearing | 28 |
ventilator | 28 |
services | 28 |
investigators | 28 |
ctpa | 28 |
receptors | 28 |
broad | 28 |
reference | 28 |
sustained | 28 |
intubated | 28 |
rse | 28 |
ncse | 28 |
parent | 28 |
working | 28 |
manifestations | 28 |
men | 28 |
performing | 28 |
reaction | 28 |
teaching | 28 |
cancers | 28 |
levetiracetam | 28 |
pro | 28 |
aha | 28 |
thrombectomy | 28 |
dual | 28 |
ultrasonography | 28 |
properties | 28 |
ensure | 28 |
applicable | 28 |
bsi | 28 |
european | 28 |
distribution | 28 |
routinely | 28 |
promote | 28 |
occlusive | 28 |
except | 28 |
doppler | 28 |
di | 28 |
define | 27 |
protective | 27 |
whose | 27 |
sct | 27 |
others | 27 |
minimum | 27 |
proper | 27 |
women | 27 |
donation | 27 |
allogeneic | 27 |
pregnancy | 27 |
pathophysiology | 27 |
crcl | 27 |
opioid | 27 |
burst | 27 |
discuss | 27 |
fully | 27 |
peg | 27 |
call | 27 |
cxr | 27 |
basal | 27 |
meeting | 27 |
timely | 27 |
lactate | 27 |
neurology | 27 |
near | 27 |
leads | 27 |
nearly | 27 |
matter | 27 |
velocities | 27 |
gi | 27 |
see | 27 |
cough | 27 |
disability | 27 |
sich | 27 |
tools | 27 |
diffusion | 27 |
classification | 27 |
ritonavir | 27 |
picc | 27 |
genomic | 27 |
directed | 27 |
regardless | 27 |
suggestive | 27 |
emergent | 27 |
referred | 27 |
activator | 27 |
pcc | 27 |
improves | 27 |
reasonable | 27 |
feedback | 27 |
nets | 27 |
complement | 27 |
contribute | 27 |
ranges | 27 |
visual | 27 |
profiles | 27 |
voxelotor | 27 |
proposed | 27 |
cox | 27 |
enzyme | 27 |
craniectomy | 27 |
dexamethasone | 26 |
odds | 26 |
exist | 26 |
rehabilitation | 26 |
lungs | 26 |
traditional | 26 |
screen | 26 |
thrombin | 26 |
crp | 26 |
understood | 26 |
reactive | 26 |
subcutaneously | 26 |
shutdown | 26 |
obtain | 26 |
angiogram | 26 |
cisplatin | 26 |
label | 26 |
fatigue | 26 |
forms | 26 |
core | 26 |
arm | 26 |
serve | 26 |
articles | 26 |
cutaneous | 26 |
paper | 26 |
fviii | 26 |
stimulation | 26 |
content | 26 |
hospitalizations | 26 |
rt | 26 |
cac | 26 |
cut | 26 |
weakness | 26 |
willebrand | 26 |
balance | 26 |
far | 26 |
accurate | 26 |
saline | 26 |
neutrophils | 26 |
cta | 26 |
vital | 26 |
supported | 26 |
regular | 26 |
sectional | 26 |
enhance | 26 |
colleagues | 26 |
returned | 26 |
excellent | 26 |
bed | 26 |
regional | 26 |
shunt | 26 |
promising | 26 |
certain | 26 |
ace | 26 |
discontinuation | 26 |
considerations | 26 |
goals | 26 |
wilms | 26 |
uncommon | 26 |
growing | 25 |
establish | 25 |
vaso | 25 |
apnea | 25 |
basic | 25 |
thrombus | 25 |
ms | 25 |
bl | 25 |
es | 25 |
ncc | 25 |
lopinavir | 25 |
vessels | 25 |
characterize | 25 |
muscle | 25 |
components | 25 |
picu | 25 |
cytotoxic | 25 |
terms | 25 |
possibly | 25 |
icd | 25 |
became | 25 |
soft | 25 |
igg | 25 |
field | 25 |
tier | 25 |
improvements | 25 |
ohio | 25 |
cascade | 25 |
pharmacokinetic | 25 |
experiences | 25 |
myoclonus | 25 |
pathological | 25 |
catheters | 25 |
characteristic | 25 |
elements | 25 |
neither | 25 |
unable | 25 |
extracted | 25 |
aims | 25 |
vomiting | 25 |
increasingly | 25 |
facilitate | 25 |
category | 25 |
elderly | 25 |
cc | 25 |
deposition | 24 |
globin | 24 |
formal | 24 |
enrolment | 24 |
cerebellar | 24 |
statement | 24 |
considering | 24 |
affecting | 24 |
deferoxamine | 24 |
missed | 24 |
august | 24 |
multimodal | 24 |
position | 24 |
professional | 24 |
readmission | 24 |
aspects | 24 |
dc | 24 |
enteral | 24 |
comparing | 24 |
hope | 24 |
living | 24 |
scenario | 24 |
supporting | 24 |
sponsor | 24 |
sub | 24 |
memory | 24 |
utility | 24 |
providing | 24 |
numbers | 24 |
reduces | 24 |
city | 24 |
relation | 24 |
lacking | 24 |
repeated | 24 |
cyclophosphamide | 24 |
microarray | 24 |
taken | 24 |
imatinib | 24 |
asked | 24 |
pharmacy | 24 |
tisagenlecleucel | 24 |
storm | 24 |
rounds | 24 |
activities | 24 |
cog | 24 |
marked | 24 |
toward | 24 |
resource | 24 |
interferon | 24 |
analyze | 24 |
compromised | 24 |
possibility | 24 |
predicting | 24 |
take | 24 |
availability | 24 |
radiotherapy | 24 |
drawn | 24 |
allopurinol | 24 |
distinct | 24 |
trait | 24 |
deletion | 24 |
skills | 24 |
cyp | 24 |
hg | 23 |
dabigatran | 23 |
achieve | 23 |
foundation | 23 |
fibrosis | 23 |
echocardiogram | 23 |
supports | 23 |
personal | 23 |
aa | 23 |
altered | 23 |
nerve | 23 |
steady | 23 |
yap | 23 |
heterozygous | 23 |
linked | 23 |
clinician | 23 |
ranging | 23 |
interventional | 23 |
structured | 23 |
stability | 23 |
anesthetic | 23 |
students | 23 |
deemed | 23 |
bleed | 23 |
removal | 23 |
carotid | 23 |
chi | 23 |
fewer | 23 |
unfavorable | 23 |
indicates | 23 |
unexpected | 23 |
curative | 23 |
net | 23 |
glycoprotein | 23 |
charts | 23 |
gcsf | 23 |
malnutrition | 23 |
perform | 23 |
crucial | 23 |
asparaginase | 23 |
african | 23 |
room | 23 |
hbss | 23 |
attributed | 23 |
worldwide | 23 |
chain | 23 |
functioning | 23 |
exome | 23 |
generated | 23 |
varied | 23 |
samd | 23 |
excluding | 23 |
adhesion | 23 |
urinary | 23 |
ews | 23 |
bmt | 23 |
drain | 23 |
summary | 23 |
trained | 23 |
comatose | 23 |
safely | 23 |
strength | 23 |
began | 23 |
challenge | 23 |
instructions | 23 |
insufficiency | 23 |
largest | 23 |
consolidation | 23 |
fevers | 23 |
lost | 23 |
swelling | 23 |
minor | 22 |
thromboplastin | 22 |
facility | 22 |
minimize | 22 |
allowed | 22 |
hypoglycemia | 22 |
find | 22 |
rr | 22 |
true | 22 |
thrombolytic | 22 |
caucasian | 22 |
normalized | 22 |
addressed | 22 |
commercial | 22 |
ncs | 22 |
wound | 22 |
correlates | 22 |
woman | 22 |
easy | 22 |
nonhospitalized | 22 |
helpful | 22 |
metabolism | 22 |
rank | 22 |
original | 22 |
interleukin | 22 |
reflect | 22 |
fixed | 22 |
unstable | 22 |
uncertain | 22 |
scenarios | 22 |
hematological | 22 |
otherwise | 22 |
go | 22 |
illnesses | 22 |
statements | 22 |
anticoagulated | 22 |
engagement | 22 |
gos | 22 |
lmp | 22 |
profound | 22 |
detailed | 22 |
demonstrating | 22 |
signal | 22 |
painful | 22 |
depending | 22 |
special | 22 |
task | 22 |
details | 22 |
workers | 22 |
crlf | 22 |
functions | 22 |
income | 22 |
extremities | 22 |
declined | 22 |
closely | 22 |
sbd | 22 |
inadequate | 22 |
assays | 22 |
indicating | 22 |
cxcr | 22 |
roc | 22 |
physiologic | 22 |
periods | 22 |
nd | 22 |
extent | 22 |
standards | 22 |
consisting | 22 |
hiv | 22 |
maintained | 22 |
port | 22 |
transcription | 22 |
thromboelastography | 22 |
eye | 22 |
rankin | 22 |
added | 22 |
prompt | 22 |
usual | 22 |
prednisone | 21 |
radiology | 21 |
copy | 21 |
consisted | 21 |
october | 21 |
diarrhea | 21 |
hemostatic | 21 |
connectivity | 21 |
fraction | 21 |
desmopressin | 21 |
gfr | 21 |
largely | 21 |
meningitis | 21 |
prbc | 21 |
mca | 21 |
aid | 21 |
robust | 21 |
alt | 21 |
strokes | 21 |
interpretation | 21 |
explored | 21 |
iph | 21 |
exposed | 21 |
inability | 21 |
thrombi | 21 |
metrics | 21 |
endpoints | 21 |
peer | 21 |
cytotoxicity | 21 |
ih | 21 |
microangiopathy | 21 |
stratified | 21 |
motor | 21 |
inform | 21 |
air | 21 |
allows | 21 |
dosage | 21 |
usage | 21 |
topics | 21 |
enough | 21 |
recanalization | 21 |
domains | 21 |
traps | 21 |
select | 21 |
agreement | 21 |
hemorrhages | 21 |
instead | 21 |
shared | 21 |
plays | 21 |
administer | 21 |
exercise | 21 |
joint | 21 |
return | 21 |
injuries | 21 |
labs | 21 |
blasts | 21 |
outbreak | 21 |
phe | 21 |
edoxaban | 21 |
never | 21 |
neuroicu | 21 |
anxiety | 21 |
publication | 21 |
ovarian | 21 |
way | 21 |
represented | 21 |
measuring | 21 |
depth | 21 |
thought | 21 |
pupillary | 21 |
diastolic | 21 |
birth | 21 |
neurosciences | 21 |
ovid | 21 |
block | 21 |
embolization | 21 |
contraindication | 21 |
inherited | 21 |
massive | 21 |
hypothesize | 21 |
feeding | 21 |
insertion | 21 |
osteonecrosis | 21 |
exhibited | 21 |
dedicated | 21 |
aware | 21 |
wbc | 21 |
submitted | 21 |
mobile | 21 |
checklist | 20 |
mers | 20 |
forty | 20 |
cvst | 20 |
minute | 20 |
poorly | 20 |
comprised | 20 |
ptld | 20 |
false | 20 |
create | 20 |
accordance | 20 |
cn | 20 |
decreases | 20 |
practitioners | 20 |
sixty | 20 |
hot | 20 |
located | 20 |
allocation | 20 |
anterior | 20 |
perceived | 20 |
comparable | 20 |
splenomegaly | 20 |
elevations | 20 |
midazolam | 20 |
pr | 20 |
recommendation | 20 |
vertebral | 20 |
subtypes | 20 |
example | 20 |
chloride | 20 |
amyloid | 20 |
transient | 20 |
emerged | 20 |
nationwide | 20 |
ray | 20 |
expanded | 20 |
cauti | 20 |
premature | 20 |
signed | 20 |
experiencing | 20 |
transfused | 20 |
nervous | 20 |
relationships | 20 |
bm | 20 |
problems | 20 |
evolving | 20 |
escalation | 20 |
mscs | 20 |
numerous | 20 |
molecule | 20 |
variety | 20 |
biopsies | 20 |
recruitment | 20 |
injections | 20 |
unusual | 20 |
immobility | 20 |
preventing | 20 |
brv | 20 |
simulation | 20 |
delays | 20 |
lumbar | 20 |
sic | 20 |
facial | 20 |
defibrotide | 20 |
genotype | 20 |
murine | 20 |
indeed | 20 |
pc | 20 |
icus | 20 |
drop | 20 |
documents | 20 |
sofa | 20 |
november | 20 |
wk | 20 |
step | 20 |
necrosis | 20 |
fio | 20 |
triage | 20 |
adjustment | 20 |
amount | 20 |
believe | 20 |
cranial | 20 |
ventilated | 20 |
validate | 19 |
stat | 19 |
plr | 19 |
list | 19 |
assist | 19 |
chelation | 19 |
sca | 19 |
induce | 19 |
operating | 19 |
optimize | 19 |
force | 19 |
dfmo | 19 |
dinutuximab | 19 |
correct | 19 |
subjective | 19 |
seems | 19 |
revised | 19 |
calls | 19 |
participate | 19 |
fact | 19 |
angiotensin | 19 |
normalization | 19 |
removed | 19 |
exchange | 19 |
centered | 19 |
cl | 19 |
immunotherapy | 19 |
reached | 19 |
node | 19 |
subgroups | 19 |
survivorship | 19 |
benign | 19 |
structure | 19 |
fellowship | 19 |
smear | 19 |
anaphylaxis | 19 |
neuroscience | 19 |
entity | 19 |
requirement | 19 |
iic | 19 |
troponin | 19 |
deviation | 19 |
bundle | 19 |
anomalies | 19 |
outpatients | 19 |
thyroid | 19 |
oncologists | 19 |
qualitative | 19 |
wall | 19 |
rs | 19 |
decreasing | 19 |
nsicu | 19 |
entry | 19 |
just | 19 |
extracorporeal | 19 |
italy | 19 |
double | 19 |
dli | 19 |
azithromycin | 19 |
prominent | 19 |
gata | 19 |
door | 19 |
leptomeningeal | 19 |
phlebotomy | 19 |
preceding | 19 |
face | 19 |
paired | 19 |
shrna | 19 |
reach | 19 |
intraventricular | 19 |
changed | 19 |
antimicrobial | 19 |
entire | 19 |
angiogenesis | 19 |
occipital | 19 |
usa | 19 |
cbf | 19 |
lysis | 19 |
definition | 19 |
ef | 19 |
correlations | 19 |
genome | 19 |
extension | 19 |
techniques | 19 |
hepatitis | 19 |
somatic | 19 |
translocation | 19 |
hand | 19 |
capillary | 18 |
acc | 18 |
splenic | 18 |
composite | 18 |
hypoxic | 18 |
wilcoxon | 18 |
vod | 18 |
methotrexate | 18 |
gastrointestinal | 18 |
always | 18 |
ganglia | 18 |
hepatotoxicity | 18 |
dnr | 18 |
issue | 18 |
eventually | 18 |
veins | 18 |
unnecessary | 18 |
achieving | 18 |
completing | 18 |
wean | 18 |
consistently | 18 |
restriction | 18 |
behavioral | 18 |
space | 18 |
ngs | 18 |
brief | 18 |
california | 18 |
portal | 18 |
platform | 18 |
airway | 18 |
electrophoresis | 18 |
infused | 18 |
nadir | 18 |
stemi | 18 |
periodic | 18 |
beginning | 18 |
discovered | 18 |
cold | 18 |
hydroxychloroquine | 18 |
infarct | 18 |
board | 18 |
beyond | 18 |
cpp | 18 |
action | 18 |
dehydrogenase | 18 |
transitioned | 18 |
rd | 18 |
corresponding | 18 |
biological | 18 |
sequence | 18 |
insufficient | 18 |
log | 18 |
section | 18 |
contraindicated | 18 |
guided | 18 |
vasopressors | 18 |
unexplained | 18 |
longitudinal | 18 |
amongst | 18 |
vancomycin | 18 |
apoptosis | 18 |
driven | 18 |
immobilization | 18 |
counseling | 18 |
situation | 18 |
conclusions | 18 |
attending | 18 |
antithrombin | 18 |
arc | 18 |
initiatives | 18 |
ha | 18 |
ayas | 18 |
exams | 18 |
adjuvant | 18 |
managing | 18 |
io | 18 |
severely | 18 |
syndromes | 18 |
telephone | 18 |
electrographic | 18 |
salvage | 18 |
slightly | 18 |
online | 18 |
mostly | 18 |
liquid | 18 |
prone | 18 |
saturation | 18 |
developmental | 18 |
fungal | 18 |
perihematomal | 18 |
tb | 18 |
variants | 18 |
interestingly | 18 |
noac | 18 |
ewing | 18 |
procoagulant | 18 |
conduct | 18 |
bereaved | 18 |
written | 18 |
alfa | 18 |
phenytoin | 18 |